A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas.
暂无分享,去创建一个
M. Salzberg | C. Sessa | S. Cresta | W. Fiedler | S. Goletz | L. Gianni | H. Baumeister | B. Dietrich | A. Tessari | J. Weidmann | S. DeDosso